Brief: Compass Pathways Establishes Strategic Collaboration With Healthport
29/04/2025 12:09
April 29 (Reuters) - Compass Pathways PLC CMPS.O: COMPASS PATHWAYS ESTABLISHES STRATEGIC COLLABORATION WITH HEALTHPORT TO INFORM THE POTENTIAL DELIVERY OF COMP360 SYNTHESIZED PSILOCYBIN TREATMENT IN UNDERSERVED COMMUNITIES Source text: ID:nBw6z9YPLa Further company coverage: CMPS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on COMPASS Pathways
See all newsBrief: Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Trump's psychedelic drug order boosts investor interest with promise of faster reviews
UK's Compass Pathways Q1 operating income beats estimates as expenses fall
Health Rounds: Researchers gain new insight into how psychedelics affect the brain
U.S. STOCKS ON THE MOVE-Eli Lilly, Compass Pathways, Charter Communications